Physician profile
Kyle William Young
NPI 1144846106
$760.77
in general payments reported to CMS, 2019-2025
9 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.53 · 2022: $263 · 2023: $144 · 2024: $99.52 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $398.17 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $260.94 | 2022-2025 | Infuse, Biotrue One Day, Biotrue |
| Alcon Vision LLC | $244.84 | 2021-2025 | Total30 |
| Optos, INC. | $76.67 | 2022 | |
| Abb Con-Cise Optical Group LLC | $48.97 | 2023 | Contact Lens, Spectacle Lenses |
| Topcon Healthcare, INC. | $44.78 | 2023 | |
| Johnson & Johnson Vision Care, INC. | $35.41 | 2023-2024 | Acuvue |
| Sight Sciences, INC. | $21.77 | 2022 | |
| Tearlab Corp | $15.19 | 2022 | |
| Coopervision INC. | $12.20 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kyle Young listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.